首页 / 院系成果 / 成果详情页

Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study 期刊论文

编号：

E7067BF762D92ACF11F457C7ADBC4954
作者：

Zhang, TianChen#^[1,2]Li, ZhenQi^[1];Jia, WeiLi^[1];Cao, Yu^[1];Hu, MingGen^[1];Wang, Kang^[3];Xu, Shuai^[4];Jiang, Tao^[5];Lin, Chao^[5];Chen, Xiong^[6];Tan, Guang^[7];Xia, NianXin^[8];Zhao, WenChao^[8];Yan, MaoLin^[9];Xu, YunFei(徐云飞)^[10]Tan, XiaoDong^[11];Zhang, Fan^[12];Wang, Xiao(王晓)^[13]Tang, YuFu^[14];Ni, QingQiang^[15];Hu, YiLin^[16];Cheng, ShuQun*^[3]Zhang, XiuPing*^[1]Liu, Rong*^[1,2]
语种：

英文
期刊：

HEPATOBILIARY SURGERY AND NUTRITION ISSN：2304-3881 2025 年 ; 2025 MAR
收录：
关键词：

Hepatocellular carcinoma (HCC) microvascular invasion (MVI) early recurrence (ER) nomogram transcatheter arterial chemoembolization (TACE)
摘要：

Background: Patients with hepatocellular carcinoma (HCC) and microvascular invasion (MVI) are susceptible to early recurrence (ER) after hepatectomy. The use of postoperative adjuvant transcatheter arterial chemoembolization (TACE) for patients with HCC and MVI remains a subject of debate. Methods: A total of 1,191 patients with HCC and MVI from 16 participating centers were retrospectively analyzed. A nomogram for predicting ER was developed using risk factors via multivariate logistic regression in the training cohort, with performance validated in the internal and external validation cohorts. Patients were categorized into high- and low-risk groups based on maximum Jordon index, which was used to continue exploring the long-term prognosis and the impact of adjuvant TACE therapy. Results: In total, 217 (43.1%), 115 (45.6%), and 189 (43.4%) patients with ER were found in the training, internal validation and external validation cohort, respectively. The DCDAM score, which incorporates diameter, cirrhosis, differentiation, alpha-fetoprotein (AFP), and MVI grade, demonstrated superior net benefit and accuracy in predicting ER compared to traditional models across three cohorts. The high-risk group (DCDAM score >169) had higher cumulative recurrence rates and worse overall survival (OS) (median OS: 22.0 vs. 38.3, 17.5 vs. 41.7, and 23.6 vs. 45.2 months, all P<0.001) compared to the low-risk group (DCDAM score <= 169) in all cohorts. TACE-adjuvant therapy improved OS in the high-risk group but not in the low-risk group. Conclusions: DCDAM score achieved an optimal postoperative prediction of ER among patients with HCC and MVI. This model can help screen subjects who can benefit more from postoperative adjuvant TACE.
推荐引用方式
GB/T 7714：

Zhang Tian-Chen,Li Zhen-Qi,Jia Wei-Li, et al. Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study [J].HEPATOBILIARY SURGERY AND NUTRITION,2025.
APA：

Zhang Tian-Chen,Li Zhen-Qi,Jia Wei-Li,Cao Yu,&Liu Rong.(2025).Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study .HEPATOBILIARY SURGERY AND NUTRITION.
MLA：

Zhang Tian-Chen, et al. "Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study" .HEPATOBILIARY SURGERY AND NUTRITION(2025).
入库时间：

4/1/2025 12:06:16 PM
更新时间：

4/1/2025 12:06:16 PM

浏览次数：19  下载次数：0

分享到：

浏览次数：19

下载次数：0

打印次数：0